EP3504327
ENGINEERED TARGET SPECIFIC NUCLEASES
:
EP einkaleyfi: Þýðing ekki lögð inn:
24.8.2017:
6.10.2021:
17844412.1
:
23.8.2037
:
ENGINEERED TARGET SPECIFIC NUCLEASES
24.8.2017
6.10.2021
:
Sangamo Therapeutics, Inc.:
7000 Marina Blvd, Brisbane, CA 94005, US
:
MILLER, Jeffrey C.:
Brisbane, CA 94005, US
:
REBAR, Edward J.:
Brisbane, CA 94005, US
:
201662378978 P:
24.8.2016:
US
:
201762443981 P:
9.1.2017:
US
:
US2017048409:
24.8.2017
:
C12N 9/22, A61K 38/00